238 related articles for article (PubMed ID: 9535824)
1. Lactacystin, proteasome function, and cell fate.
Fenteany G; Schreiber SL
J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
[No Abstract] [Full Text] [Related]
2. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
Fenteany G; Standaert RF; Lane WS; Choi S; Corey EJ; Schreiber SL
Science; 1995 May; 268(5211):726-31. PubMed ID: 7732382
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone.
Dick LR; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Stein RL
J Biol Chem; 1996 Mar; 271(13):7273-6. PubMed ID: 8631740
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitinylation and proteasome-dependent degradation of the phosphoinositide-specific phospholipase C gamma 1 in A-431 cells.
Evdonin AL; Tsupkina NV; Nikol'skii NN; Medvedeva ND
Dokl Biol Sci; 2003; 392():456-7. PubMed ID: 14650885
[No Abstract] [Full Text] [Related]
5. Lactacystin augments the sulindac-induced apoptosis in HT-29 cells.
Choi HJ; Kim HH; Lee HS; Huh GY; Seo SY; Jeong JH; Kim JM; Yoo YH
Apoptosis; 2003 Jun; 8(3):301-5. PubMed ID: 12766490
[TBL] [Abstract][Full Text] [Related]
6. Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts.
Sitte N; Merker K; Grune T
FEBS Lett; 1998 Dec; 440(3):399-402. PubMed ID: 9872410
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
Wagenknecht B; Hermisson M; Eitel K; Weller M
Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
[TBL] [Abstract][Full Text] [Related]
8. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
[TBL] [Abstract][Full Text] [Related]
9. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
Ostrowska H; Wojcik C; Omura S; Worowski K
Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
[TBL] [Abstract][Full Text] [Related]
10. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of proteasome to its inhibitors increases during cAMP-induced differentiation of neuroblastoma cells in culture and causes decreased viability.
Kumar B; Hanson AJ; Prasad KN
Cancer Lett; 2004 Feb; 204(1):53-9. PubMed ID: 14744534
[TBL] [Abstract][Full Text] [Related]
12. Lactacystin increases LDL receptor level on HepG2 cells.
Miura H; Tomoda H; Miura K; Takishima K; Omura S
Biochem Biophys Res Commun; 1996 Oct; 227(3):684-7. PubMed ID: 8885994
[TBL] [Abstract][Full Text] [Related]
13. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
[TBL] [Abstract][Full Text] [Related]
14. Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells.
Nahreini P; Andreatta C; Prasad KN
Cell Mol Neurobiol; 2001 Oct; 21(5):509-21. PubMed ID: 11860188
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors block development of Plasmodium spp.
Gantt SM; Myung JM; Briones MR; Li WD; Corey EJ; Omura S; Nussenzweig V; Sinnis P
Antimicrob Agents Chemother; 1998 Oct; 42(10):2731-8. PubMed ID: 9756786
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
Dick LR; Cruikshank AA; Destree AT; Grenier L; McCormack TA; Melandri FD; Nunes SL; Palombella VJ; Parent LA; Plamondon L; Stein RL
J Biol Chem; 1997 Jan; 272(1):182-8. PubMed ID: 8995245
[TBL] [Abstract][Full Text] [Related]
17. Proteasome activity is required for the stage-specific transformation of a protozoan parasite.
González J; Ramalho-Pinto FJ; Frevert U; Ghiso J; Tomlinson S; Scharfstein J; Corey EJ; Nussenzweig V
J Exp Med; 1996 Nov; 184(5):1909-18. PubMed ID: 8920878
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
Ogiso Y; Tomida A; Lei S; Omura S; Tsuruo T
Cancer Res; 2000 May; 60(9):2429-34. PubMed ID: 10811120
[TBL] [Abstract][Full Text] [Related]
19. Proteasome pathway operates for the degradation of ornithine decarboxylase in intact cells.
Murakami Y; Tanahashi N; Tanaka K; Omura S; Hayashi S
Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):77-80. PubMed ID: 8694789
[TBL] [Abstract][Full Text] [Related]
20. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
